MỘT SỐ ĐẶC ĐIỂM VÀ KẾT QUẢ ĐIỀU TRỊ BỆNH NHÂN UNG THƯ KHẨU HẦU TẠI BỆNH VIỆN UNG BƯỚU CẦN THƠ NĂM 2020

Abstract

 Background: Oropharyngeal cancer is common cancer in the world as well as in Vietnam. Assessing oropharyngeal cancer is necessary to provide data for recommendations on prevention, early detection and treatment. Objectives: To describe the features and treatment results of oropharyngeal cancer patients at Can Tho Oncology Hospital in 2020. Materials and Methods: A cross-sectional descriptive study was carried out of 71 patients diagnosed with oropharyngeal cancer, they have been treated in Can Tho Oncology Hospital in 2020. Results: The rates of tonsillar cancer, the base of tongue cancer, soft palate cancer, posterior and lateral oropharyngeal wall cancer were 26.8%, 39.4%, 18.3%, and 15.5%, respectively. The squamous cell carcinomas accounted for 83.1%, and histologic grade 2 accounted for 78%. The stage IVA was 67.8%. The primary treatment options included concurrent chemoradiotherapy 47,2%, induction chemotherapy 33.3%, radiation alone 16.7% and surgery 2.8%. Among those patients, 13.9% have achieved complete response, 44,4% have achieved partial response, 27.8% have been stable disease, and 13.9% have been progressive disease. Conclusion: The common location of oropharynx cancer is the tongue base. Squamous cell carcinoma, grade 2, is the most common. Concurrent chemoradiotherapy is the most common options treatment method. The overall response rate was 58.3%.